{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:03:42Z","timestamp":1768874622130,"version":"3.49.0"},"reference-count":37,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2014,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Since 2011, outbreaks caused by influenza A(H3N2) variant [A(H3N2)v] viruses have become a public health concern in the United States. The A(H3N2)v viruses share the A(H1N1)pdm09 M gene containing the marker of M2 blocker resistance, S31N, but do not contain any known molecular markers associated with resistance to neuraminidase (NA) inhibitors (NAIs). Using a fluorescent NA inhibition (NI) assay, the susceptibilities of recovered A(H3N2)v viruses (\n            <jats:italic>n<\/jats:italic>\n            = 168) to FDA-approved (oseltamivir and zanamivir) and other (peramivir, laninamivir, and A-315675) NAIs were assessed. All A(H3N2)v viruses tested, with the exception of a single virus strain, A\/Ohio\/88\/2012, isolated from an untreated patient, were susceptible to the NAIs tested. The A\/Ohio\/88\/2012 virus contained two rare substitutions, S245N and S247P, in the NA and demonstrated reduced inhibition by oseltamivir (31-fold) and zanamivir (66-fold) in the NI assay. Using recombinant NA (recNA) proteins, S247P was shown to be responsible for the observed altered NAI susceptibility, in addition to an approximately 60% reduction in NA enzymatic activity. The S247P substitution has not been previously reported as a molecular marker of reduced susceptibility to the NAIs. Using cell culture assays, the investigational antiviral drugs nitazoxanide, favipiravir, and fludase were shown to inhibit the replication of A(H3N2)v viruses, including the virus with the S247P substitution in the NA. This report demonstrates the importance of continuous monitoring of susceptibility of zoonotic influenza viruses to available and investigational antiviral drugs.\n          <\/jats:p>","DOI":"10.1128\/aac.02556-13","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T03:59:58Z","timestamp":1390363198000},"page":"2045-2051","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":34,"title":["Antiviral Susceptibility of Variant Influenza A(H3N2)v Viruses Isolated in the United States from 2011 to 2013"],"prefix":"10.1128","volume":"58","author":[{"given":"K.","family":"Sleeman","sequence":"first","affiliation":[{"name":"Virology, Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. P.","family":"Mishin","sequence":"additional","affiliation":[{"name":"Virology, Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Guo","sequence":"additional","affiliation":[{"name":"Virology, Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. J.","family":"Garten","sequence":"additional","affiliation":[{"name":"Virology, Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Balish","sequence":"additional","affiliation":[{"name":"Virology, Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Fry","sequence":"additional","affiliation":[{"name":"Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Villanueva","sequence":"additional","affiliation":[{"name":"Virology, Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Stevens","sequence":"additional","affiliation":[{"name":"Virology, Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. V.","family":"Gubareva","sequence":"additional","affiliation":[{"name":"Virology, Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1993.1155"},{"key":"e_1_3_2_3_2","volume-title":"International health regulations (2005)","author":"World Health Organization","year":"2005","unstructured":"World Health Organization. 2005. International health regulations (2005), 2nd ed. World Health Organization, Geneva, Switzerland.","edition":"2"},{"key":"e_1_3_2_4_2","unstructured":"Council of State and Territorial Epidemiologists. 2007. National reporting for initial detections of novel influenza A viruses. Position statement 07-ID01. http:\/\/c.ymcdn.com\/sites\/www.cste.org\/resource\/resmgr\/PS\/07-ID-01.pdf. Accessed 12 December 2012."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2011.10.016"},{"key":"e_1_3_2_6_2","first-page":"1741","article-title":"Update: influenza A (H3N2)v transmission and guidelines\u2014five states, 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2012","unstructured":"Centers for Disease Control and Prevention. 2012. Update: influenza A (H3N2)v transmission and guidelines\u2014five states, 2011. MMWR Morb. Mortal. Wkly. Rep. 60:1741\u20131744. http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6051a4.htm.","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1805.111922"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.05794-11"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002443"},{"key":"e_1_3_2_10_2","unstructured":"Centers for Disease Control and Prevention. 2013. Case count: detected U.S. human infections with H3N2v by state since August 2011. http:\/\/www.cdc.gov\/flu\/swineflu\/h3n2v-case-count.htm. Accessed 5 June 2013."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit649"},{"key":"e_1_3_2_12_2","first-page":"1615","article-title":"Limited human-to-human transmission of novel influenza A (H3N2) virus\u2014Iowa, November 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","unstructured":"Centers for Disease Control and Prevention. 2011. Limited human-to-human transmission of novel influenza A (H3N2) virus\u2014Iowa, November 2011. MMWR Morb. Mortal. Wkly. Rep. 60:1615\u20131617. http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6047a3.htm.","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_13_2","first-page":"764","article-title":"Influenza A (H3N2) variant virus-related hospitalizations\u2014Ohio, 2012","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","unstructured":"Centers for Disease Control and Prevention. 2012. Influenza A (H3N2) variant virus-related hospitalizations\u2014Ohio, 2012. MMWR Morb. Mortal. Wkly. Rep. 61:764\u2013767. http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6138a3.htm.","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_14_2","first-page":"619","article-title":"Evaluation of rapid influenza diagnostic tests for influenza A (H3N2)v virus and updated case count\u2014United States, 2012","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","unstructured":"Centers for Disease Control and Prevention. 2012. Evaluation of rapid influenza diagnostic tests for influenza A (H3N2)v virus and updated case count\u2014United States, 2012. MMWR Morb. Mortal. Wkly. Rep. 61:619\u2013621. http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6132a4.htm.","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02625-12"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12049"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007788"},{"key":"e_1_3_2_18_2","volume-title":"Manual for the laboratory diagnosis and virological surveillance of influenza","author":"World Health Organization Global Influenza Surveillance Network","year":"2011","unstructured":"World Health Organization Global Influenza Surveillance Network. 2011. Manual for the laboratory diagnosis and virological surveillance of influenza. WHO Press, Geneva, Switzerland. http:\/\/whqlibdoc.who.int\/publications\/2011\/9789241548090_eng.pdf."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12113"},{"key":"e_1_3_2_20_2","first-page":"369","article-title":"Meetings of the WHO working group on surveillance of influenza antiviral susceptibility\u2014Geneva, November 2011 and June 2012","volume":"87","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. 2012. Meetings of the WHO working group on surveillance of influenza antiviral susceptibility\u2014Geneva, November 2011 and June 2012. Wkly. Epidemiol. Rec. 87:369\u2013380. http:\/\/www.who.int\/wer\/2012\/wer8739\/en\/index.html.","journal-title":"Wkly. Epidemiol. Rec."},{"key":"e_1_3_2_21_2","unstructured":"World Health Organization. 2013. Laboratory methodologies for testing the antiviral susceptibility of influenza viruses: neuraminidase inhibitor (NAI). http:\/\/www.who.int\/influenza\/gisrs_laboratory\/antiviral_susceptibility\/nai_overview\/en\/index.html. Accessed 6 November 2013."},{"key":"e_1_3_2_22_2","first-page":"95","article-title":"BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT","volume":"41","author":"Hall TA","year":"1999","unstructured":"HallTA. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT. Nucleic Acids Symp. Ser. 41:95\u201398.","journal-title":"Nucleic Acids Symp. Ser."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2008.08.008"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00959-08"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.15.8418-8425.2003"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/891010"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01739-09"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg520"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.03.014"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01200-09"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2009.11.005"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00555-08"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01364-13"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1119945109"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2067"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis623"},{"key":"e_1_3_2_37_2","unstructured":"BelardoGLa FraziaSCenciarelliOCartaSRossignolJ-FSantoroMG. 2011. Nitazoxanide a novel potential anti-influenza drug acting in synergism with neuraminidase inhibitors. IDSA%202011%20NTZ%20poster%20Belardo%20et%20al%20Final%20100611.pdf. Accessed 18 November 2013."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.029470"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02556-13","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02556-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:41:16Z","timestamp":1645483276000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02556-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["10.1128\/AAC.02556-13"],"URL":"https:\/\/doi.org\/10.1128\/aac.02556-13","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"2013-11-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-01-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-03-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}